Asia Pacific mHealth market projects a remarkable growth rate, supplemented with the growing awareness of mHealth devices and services that aid in improve the quality of life for patients stricken with lifestyle diseases. The growing prevalence of lifestyle diseases such as diabetes, obesity, hypertension, chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA), in Asia Pacific region, creates an impending need of technologically advanced platforms for the prevention and treatment of these diseases. According to the National Institute of Health, China and India are the two highest populated nations, with an approximate diabetes count of 150 million patients. Thus, the need for regular health monitoring and treatment would be addressed by launch of smartphone-based medical devices.
The Asia Pacific mHealth market was evaluated at $2.3 billion in 2014, and is expected to register a CAGR of 35.8% during the forecast period (2015 to 2020). This growth is primarily driven by active government initiatives and the rising adoption of smartphones in Asia-pacific region. Presently, the market is witnessing a resurgence due to the increasing disposable incomes and the growing adoption of mobile phones. Moreover, a similar trend is observed in developing countries like India and Indonesia. However, factors such as consumers affordability, access to healthcare services and inaccuracy in results arising from discrepancies in devices would limit the growth of the market.
Themarket is segmented into devices, services, application, stakeholders and geography. Based on device type, the market is segmented into blood glucose meters, BP monitors, pulse oximetry, neurological monitoring devices, apnea and sleep monitors, wearable fitness sensor device & heart rate meters and others. The BP monitors segment holds a dominant share; however, the blood glucose meters segment is estimated to register the fastest growth in the Asia Pacific mHealth devices market. Factors such as incidences of hypertension, sedentary lifestyles, the increasing count of diabetics, supplement the adoption of mHealth devices. Based on services, the market is segmented into diagnosis services, monitoring services, prevention, treatment and wellness & healthcare system strengthening solutions. The monitoring services segment holds a dominant share in the Asia Pacific mHealth services market and would register the highest CAGR throughout the forecast period (2015-2020). Based on stake holders, the market is segmented into mobile operators, device vendors, healthcare providers and application players. Within the segment of stakeholders, mobile operators occupy a dominant share in themarket. The segment of mobile application developers would register the highest CAGR during the forecast period (2015-2020). Based on applications, the industry is segmented into cardiovascular diseases, diabetes, respiratory diseases, neurological diseases and others. The cardiovascular diseases segment holds a dominant share in the Asia Pacific mHealth applications market; however, the diabetes application segment is expected to register the highest CAGR during the forecast period (2015-2020). Based on country, the market is segmented across Australia, China, Japan, India and Rest of Asia Pacific. China accounts for the largest market share, whilst India is the fastest growing region in thismarket.
The key players profiled in this report include - Philips Healthcare, Omron HealthCare, Inc., Bayer Healthcare, LifeWatch AG, Masimo Corporation, Sanofi S.A., Boston Scientific Corporation, AT&T Inc. and Johnson & Johnson.
ASIA PACIFIC mHEALTH MARKET KEY SEGMENTS:
SIMILAR MARKET STUDIES
Glucose Meter is a medical device for determining the approximate concentration of glucose in the blood. It can also be a strip of glucose paper dipped into a substance and measured to the glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes ...
September 2017 | $4880 | View Details >>
This report studies the Pet Insurance market, Pet insurance is a type of specialty property and casualty insurance policy that pet owners purchase to cover the unintended costs that arise in providing care for a pet, including veterinary services such as surgical procedures, injuries from accidents, and prescribed pet medicines. ...
September 2017 | $4880 | View Details >>
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Biofeedback Instrument in these regions, from 2012 to 2022 (forecast), covering North America Europe China Asia (Ex. China) RoW The major players in global Biofeedback Instrument market include Thought Technology Ltd Laborie Qxsubspace Vishee Quantum World Vision BrainMaster Technologies, Inc. Mind Media NeuroCare Allengers Medical Systems ELMIKO NCC ...
September 2017 | $2900 | View Details >>
This report studies the Irreversible Electroporation Ablators market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Irreversible Electroporation Ablators market by product type and applications/end industries. The ...
September 2017 | $4000 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research